Simplex Trading
RCEL icon

Simplex Trading’s Avita Medical RCEL Stock Holding History

Simplex Trading’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14 Buy
+4
New +$17 ﹤0.01% 8922
2025
Q2 		– Sell
-1,130
Closed -$8.22K – 9555
2025
Q1 		$9K Buy
+1,130
New +$10.6K ﹤0.01% 7194
2024
Q3 		– Sell
-3,510
Closed -$33K – 9373
2024
Q2 		$27K Buy
3,510
+3,113
+784% +$29.6K ﹤0.01% 6650
2024
Q1 		$6K Sell
397
-2,169
-85% -$35.1K ﹤0.01% 7939
2023
Q4 		$35K Buy
+2,566
New +$29.4K ﹤0.01% 6432
2023
Q3 		– Sell
-13,796
Closed -$233K – 9614
2023
Q2 		$234K Buy
13,796
+11,951
+648% +$175K ﹤0.01% 4121
2023
Q1 		$25K Sell
1,845
-9,668
-84% -$103K ﹤0.01% 6683
2022
Q4 		$75K Sell
11,513
-26,298
-70% -$158K ﹤0.01% 5397
2022
Q3 		$199K Sell
37,811
-15,472
-29% -$95.5K ﹤0.01% 4616
2022
Q2 		$253K Buy
53,283
+49,686
+1,381% +$307K ﹤0.01% 4321
2022
Q1 		$30K Buy
+3,597
New +$33.2K ﹤0.01% 7774
2021
Q4 		– Sell
-164
Closed -$2.5K – 11264
2021
Q3 		$3K Hold
164
– – ﹤0.01% 9451
2021
Q2 		$3K Sell
164
-1,336
-89% -$26.3K ﹤0.01% 9637
2021
Q1 		$29K Buy
+1,500
New +$34.9K ﹤0.01% 7154
2020
Q4 		– Sell
-1,565
Closed -$34.3K – 8927
2020
Q3 		$39K Sell
1,565
-200
-11% -$4.99K ﹤0.01% 5849
2020
Q2 		$53K Buy
+1,765
New +$54K ﹤0.01% 5442

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplex Trading's RCEL Position: Q1 2026 in Review

Simplex Trading opened a new position in Avita Medical (RCEL) in Q1 2026: 4 shares worth $14. The stake represents ﹤0.01% of the portfolio and ranks #8922 among its holdings. This is a return to the name: Simplex Trading previously reported a position in RCEL as recently as Q1 2025.

Simplex Trading first reported a position in RCEL in Q2 2020 and has held it in 16 quarters since. The position peaked at $253K in Q2 2022. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • Simplex Trading held 4 shares of Avita Medical worth $14 as of Q1 2026.
  • Avita Medical was a new Simplex Trading position in Q1 2026.
  • Avita Medical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8922 holding.
  • Simplex Trading first reported a position in Avita Medical in Q2 2020 and has held it in 16 quarters since.
  • Simplex Trading's Avita Medical position peaked at $253K in Q2 2022.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.